Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroyuki Futani

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Medicine|August 27, 2021
Long-term survival following radiofrequency ablation of lung metastases in an elderly patient with calcaneal osteosarcoma: A case report and review of the literatureHiroyuki Futani, Haruyuki Takaki, Tatsuo Sawai, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|September 10, 2009
Immunotherapy with interleukin-18 in combination with preoperative chemotherapy with ifosfamide effectively inhibits postoperative progression of pulmonary metastases in a mouse osteosarcoma modelNaoko Yamada, Masaki Hata, Hideki Ohyama, et al.
International Journal of Oncology|March 18, 2015
Sodium valproate, a histone deacetylase inhibitor, modulates the vascular endothelial growth inhibitor-mediated cell death in human osteosarcoma and vascular endothelial cellsKoji Yamanegi, Mutsuki Kawabe, Hiroyuki Futani, et al.
Pathology, Research and Practice|July 5, 2018
An extremely rare case of primary malignancy in giant cell tumor of bone, arising in the right femur and harboring H3F3A mutationYoshitane Tsukamoto, Hiroyuki Futani, Takako Kihara, et al.
Arthritis and Rheumatism|July 30, 2005
Endogenous interleukin-6, but not tumor necrosis factor alpha, contributes to the development of toll-like receptor 4/myeloid differentiation factor 88-mediated acute arthritis in miceFumiyasu Kyo, Hiroyuki Futani, Kiyoshi Matsui, et al.
Oncology Reports|October 11, 2002
Interleukin-18 inhibits lodging and subsequent growth of human multiple myeloma cells in the bone marrowKunihiro Yamashita, Teruo Iwasaki, Tohru Tsujimura, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 6, 2002
Relation between interleukin-18 and PGE2 in synovial fluid of osteoarthritis: a potential therapeutic target of cartilage degradationHiroyuki Futani, Akira Okayama, Kiyoshi Matsui, et al.
Biochemistry and Biophysics Reports|January 25, 2021
Programmed cell death 1 positive lymphocytes at palate tonsils in the elder patients with chronic tonsillitisYuki Fujihara, Koji Yamanegi, Yasuyuki Nagasawa, et al.
Anticancer Research|March 9, 2012
Small cell osteosarcoma successfully treated by high-dose ifosfamide and methotrexate, combined with carboplatin and pirarubicinHiroyuki Futani, Satoru Fukunaga, Yoshitane Tsukamoto, et al.
Cancer Immunology, Immunotherapy : CII|January 13, 2006
Effect of interleukin-18 on metastasis of mouse osteosarcoma cellsYoshiteru Nakamura, Naoko Yamada, Hideki Ohyama, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Medicine|August 27, 2021
Long-term survival following radiofrequency ablation of lung metastases in an elderly patient with calcaneal osteosarcoma: A case report and review of the literatureHiroyuki Futani, Haruyuki Takaki, Tatsuo Sawai, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|September 10, 2009
Immunotherapy with interleukin-18 in combination with preoperative chemotherapy with ifosfamide effectively inhibits postoperative progression of pulmonary metastases in a mouse osteosarcoma modelNaoko Yamada, Masaki Hata, Hideki Ohyama, et al.
International Journal of Oncology|March 18, 2015
Sodium valproate, a histone deacetylase inhibitor, modulates the vascular endothelial growth inhibitor-mediated cell death in human osteosarcoma and vascular endothelial cellsKoji Yamanegi, Mutsuki Kawabe, Hiroyuki Futani, et al.
Pathology, Research and Practice|July 5, 2018
An extremely rare case of primary malignancy in giant cell tumor of bone, arising in the right femur and harboring H3F3A mutationYoshitane Tsukamoto, Hiroyuki Futani, Takako Kihara, et al.
Arthritis and Rheumatism|July 30, 2005
Endogenous interleukin-6, but not tumor necrosis factor alpha, contributes to the development of toll-like receptor 4/myeloid differentiation factor 88-mediated acute arthritis in miceFumiyasu Kyo, Hiroyuki Futani, Kiyoshi Matsui, et al.
Oncology Reports|October 11, 2002
Interleukin-18 inhibits lodging and subsequent growth of human multiple myeloma cells in the bone marrowKunihiro Yamashita, Teruo Iwasaki, Tohru Tsujimura, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 6, 2002
Relation between interleukin-18 and PGE2 in synovial fluid of osteoarthritis: a potential therapeutic target of cartilage degradationHiroyuki Futani, Akira Okayama, Kiyoshi Matsui, et al.
Biochemistry and Biophysics Reports|January 25, 2021
Programmed cell death 1 positive lymphocytes at palate tonsils in the elder patients with chronic tonsillitisYuki Fujihara, Koji Yamanegi, Yasuyuki Nagasawa, et al.
Anticancer Research|March 9, 2012
Small cell osteosarcoma successfully treated by high-dose ifosfamide and methotrexate, combined with carboplatin and pirarubicinHiroyuki Futani, Satoru Fukunaga, Yoshitane Tsukamoto, et al.
Cancer Immunology, Immunotherapy : CII|January 13, 2006
Effect of interleukin-18 on metastasis of mouse osteosarcoma cellsYoshiteru Nakamura, Naoko Yamada, Hideki Ohyama, et al.
Pageof 5